$127.76
Price
$12.8B
Market Cap
27.4
P/E Ratio
13.3
Forward P/E
$4.67
EPS (TTM)
—
Dividend Yield
$1.5B
Cash
$415M
Total Debt
100M
Shares Out
$84.23
$160.18
52-Week Range
Institutional Ownership of NEUROCRINE BIOSCIENCES INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for NEUROCRINE BIOSCIENCES INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| No activity found for this stock. | |||||
Insider Trading for NEUROCRINE BIOSCIENCES INC
6 Months Insider Sentiment
Buy $0
Sell $9.8M
0
Buys
8
Sells
-9.8M
Net
2
Grants
Largest
$2.7M
Rastetter
$2.3M
A
$2.2M
J
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jan 08, 2026 | Darin Lippoldt | Chief Legal Officer | EXERCISE | 3.3K | $35.99 | $121K |
| Dec 16, 2025 | Leslie V Norwalk | Director | SELL | 1.2K | $155.09 | $185K |
| Dec 15, 2025 | Leslie V Norwalk | Director | SELL | 5.0K | $152.23 | $761K |
| Dec 15, 2025 | Leslie V Norwalk | Director | EXERCISE | 8.3K | $92.35 | $764K |
| Dec 15, 2025 | Leslie V Norwalk | Director | EXERCISE | 1.7K | $84.95 | $146K |
| Dec 08, 2025 | Darin Lippoldt | Chief Legal Officer | SELL | 4.4K | $159.65 | $699K |
| Dec 08, 2025 | Darin Lippoldt | Chief Legal Officer | EXERCISE | 4.4K | $43.24 | $189K |
| Dec 03, 2025 | LYONS GARY A | Director | EXERCISE | 15.0K | $47.89 | $718K |
| Dec 03, 2025 | LYONS GARY A | Director | SELL | 15.0K | $152.61 | $2.3M |
| Nov 29, 2025 | Jude Onyia | Chief Scientific Officer | EXERCISE | 4.4K | — | — |
| Nov 28, 2025 | Eric Benevich | Chief Commercial Officer | SELL | 6.0K | $151.74 | $906K |
| Nov 28, 2025 | Eric Benevich | Chief Commercial Officer | EXERCISE | 6.0K | $35.99 | $215K |
| Nov 28, 2025 | Eric Benevich | Chief Commercial Officer | EXERCISE | 12.8K | $35.99 | $462K |
| Nov 25, 2025 | MORROW GEORGE J | Director | EXERCISE | 15.0K | $47.89 | $718K |
| Nov 25, 2025 | MORROW GEORGE J | Director | SELL | 15.0K | $143.37 | $2.2M |
| Nov 05, 2025 | William H Rastetter | Director | SELL | 18.0K | $151.82 | $2.7M |
| Nov 05, 2025 | William H Rastetter | Director | EXERCISE | 18.0K | $47.89 | $862K |
| Nov 04, 2025 | Kyle Gano | Chief Executive Officer | SELL | 300 | $141.97 | $43K |
| Nov 01, 2025 | Kyle Gano | Chief Executive Officer | EXERCISE | 613 | — | — |
| Sep 03, 2025 | Jude Onyia | Chief Scientific Officer | GRANT | 1.5K | — | — |
| Sep 02, 2025 | SHERWIN STEPHEN A | Director | GRANT | 1.0K | — | — |